[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE9300937L - Komposition för oral administrering av peptider - Google Patents

Komposition för oral administrering av peptider

Info

Publication number
SE9300937L
SE9300937L SE9300937A SE9300937A SE9300937L SE 9300937 L SE9300937 L SE 9300937L SE 9300937 A SE9300937 A SE 9300937A SE 9300937 A SE9300937 A SE 9300937A SE 9300937 L SE9300937 L SE 9300937L
Authority
SE
Sweden
Prior art keywords
pct
oral administration
spheres
date sep
sec
Prior art date
Application number
SE9300937A
Other languages
English (en)
Other versions
SE9300937D0 (sv
Inventor
Anne Fjellestad-Paulsen
Original Assignee
Anne Fjellestad Paulsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anne Fjellestad Paulsen filed Critical Anne Fjellestad Paulsen
Priority to SE9300937A priority Critical patent/SE9300937L/sv
Publication of SE9300937D0 publication Critical patent/SE9300937D0/sv
Priority to US08/525,584 priority patent/US5780434A/en
Priority to DK94911346T priority patent/DK0689452T3/da
Priority to ES94911346T priority patent/ES2135570T3/es
Priority to EP94911346A priority patent/EP0689452B1/en
Priority to DE69419246T priority patent/DE69419246T2/de
Priority to PCT/SE1994/000244 priority patent/WO1994021286A1/en
Priority to AU63889/94A priority patent/AU6388994A/en
Priority to AT94911346T priority patent/ATE181508T1/de
Publication of SE9300937L publication Critical patent/SE9300937L/sv
Priority to GR990402412T priority patent/GR3031312T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE9300937A 1993-03-19 1993-03-19 Komposition för oral administrering av peptider SE9300937L (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9300937A SE9300937L (sv) 1993-03-19 1993-03-19 Komposition för oral administrering av peptider
AT94911346T ATE181508T1 (de) 1993-03-19 1994-03-18 Zusammensetzungen zur oralen verabreichung von peptiden
EP94911346A EP0689452B1 (en) 1993-03-19 1994-03-18 Composition for oral administration of peptides
DK94911346T DK0689452T3 (da) 1993-03-19 1994-03-18 Sammensætning til oral administration af peptider
ES94911346T ES2135570T3 (es) 1993-03-19 1994-03-18 Composicion para la administracion oral de peptidos.
US08/525,584 US5780434A (en) 1993-03-19 1994-03-18 Composition for oral administration of peptides
DE69419246T DE69419246T2 (de) 1993-03-19 1994-03-18 Zusammensetzungen zur oralen verabreichung von peptiden
PCT/SE1994/000244 WO1994021286A1 (en) 1993-03-19 1994-03-18 Composition for oral administration of peptides
AU63889/94A AU6388994A (en) 1993-03-19 1994-03-18 Composition for oral administration of peptides
GR990402412T GR3031312T3 (en) 1993-03-19 1999-09-22 Composition for oral administration of peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300937A SE9300937L (sv) 1993-03-19 1993-03-19 Komposition för oral administrering av peptider

Publications (2)

Publication Number Publication Date
SE9300937D0 SE9300937D0 (sv) 1993-03-19
SE9300937L true SE9300937L (sv) 1994-09-20

Family

ID=20389308

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9300937A SE9300937L (sv) 1993-03-19 1993-03-19 Komposition för oral administrering av peptider

Country Status (10)

Country Link
US (1) US5780434A (sv)
EP (1) EP0689452B1 (sv)
AT (1) ATE181508T1 (sv)
AU (1) AU6388994A (sv)
DE (1) DE69419246T2 (sv)
DK (1) DK0689452T3 (sv)
ES (1) ES2135570T3 (sv)
GR (1) GR3031312T3 (sv)
SE (1) SE9300937L (sv)
WO (1) WO1994021286A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
CA2428114C (en) 2000-11-10 2013-07-23 Proteopharma Aps Apolipoprotein analogues
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
ATE324869T1 (de) * 2003-11-13 2006-06-15 Ferring Bv Blisterverpackung und feste dosierungsform enthaltend desmopressin
US20090169566A1 (en) 2004-11-22 2009-07-02 Anadis Ltd. Bioactive compositions
EP2179741B1 (en) 2005-08-26 2014-10-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for treatment of headaches by administraton of oxytocin
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
BRPI0814986A2 (pt) 2007-08-06 2015-02-03 Serenity Pharmaceuticals Corp Métodos e dispositivos para a distribuição de fármaco desmopresina.
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
PL2296686T5 (pl) * 2008-05-21 2018-06-29 Ferring B.V. Ulegająca rozpadowi w ustach desmopresyna do zwiększania początkowego okresu snu niezakłócanego przez nokturię
BRPI1015046A2 (pt) 2009-06-18 2016-04-12 Allergan Inc administração segura de desmopressina
WO2016112205A1 (en) 2015-01-07 2016-07-14 Trigemina, Inc. Magnesium-containing oxytocin formulations and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139504A (en) * 1977-06-16 1979-02-13 Coy David Howard Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
JPS608225A (ja) * 1983-06-29 1985-01-17 Kowa Co 腸管吸収医薬組成物
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
ATE122357T1 (de) * 1988-01-28 1995-05-15 Polygen Holding Corp Polypeptide mit hormonwachstumsbefreiender wirkung.
DE3919982A1 (de) * 1989-06-19 1990-12-20 Liedtke Pharmed Gmbh Orale lipidarzneiform
JP3009911B2 (ja) * 1989-06-28 2000-02-14 エーザイ株式会社 ペプチド又は蛋白の内服用新規製剤
JPH04364131A (ja) * 1991-04-03 1992-12-16 Sanwa Kagaku Kenkyusho Co Ltd 易吸収性モチリン製剤
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments

Also Published As

Publication number Publication date
WO1994021286A1 (en) 1994-09-29
DE69419246T2 (de) 2000-01-20
AU6388994A (en) 1994-10-11
DE69419246D1 (de) 1999-07-29
SE9300937D0 (sv) 1993-03-19
EP0689452B1 (en) 1999-06-23
GR3031312T3 (en) 1999-12-31
DK0689452T3 (da) 1999-12-13
ES2135570T3 (es) 1999-11-01
ATE181508T1 (de) 1999-07-15
EP0689452A1 (en) 1996-01-03
US5780434A (en) 1998-07-14

Similar Documents

Publication Publication Date Title
FI114688B (sv) Stabiliserad sammansättning för oral administration av peptider
SE9300937L (sv) Komposition för oral administrering av peptider
EP0225189A3 (en) Targeted enteral delivery system
KR100197465B1 (en) Rapidly disintegratable multiparticulate tablet
EP1275381A4 (en) SOLID COATED PREPARATIONS WITH TEMPERATURE RELEASE FOR ORAL ADMINISTRATION
ZA952169B (en) Pharmaceutical compositions
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
SK169999A3 (en) Controlled release pharmaceutical preparation with ace inhibitor as active agent
RU2449796C9 (ru) Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива
GB2405094A (en) Pharmaceutical composition for controlled drug delivery system
IL41524A (en) Pharmaceutical preparations containing the product of proline
MX9802026A (es) Formulaciones farmaceuticas que contienen darifenacina.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9300937-1